ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Ischemic stroke in children and young adults: Epidemiology, etiology, and risk factors

Ischemic stroke in children and young adults: Epidemiology, etiology, and risk factors
Literature review current through: Jan 2024.
This topic last updated: Oct 27, 2023.

INTRODUCTION — Although more common in older adults, stroke also occurs in neonates, infants, children, and young adults, resulting in significant morbidity and mortality.

An overview of the epidemiology, risk factors, etiology, clinical presentation, and differential diagnosis of arterial ischemic stroke in children ≥1 month of age and adults <50 years of age is provided here.

Other aspects of ischemic stroke in children and young adults are reviewed elsewhere. (See "Ischemic stroke in children: Clinical presentation, evaluation, and diagnosis" and "Ischemic stroke in children: Management and prognosis" and "Stroke in the newborn: Classification, manifestations, and diagnosis" and "Cerebral venous thrombosis: Etiology, clinical features, and diagnosis".)

EPIDEMIOLOGY — Stroke occurrence increases exponentially with age (figure 1) [1].

Infants and children – Annual incidence rates of arterial ischemic stroke in infants and children range from 0.6 to 7.9/100,000 children per year [2-5].

Several studies have found that pediatric ischemic stroke is more common in boys than in girls [6-8]. As an example, among 1187 children in a multinational pediatric stroke registry, boys accounted 540 of 925 cases (58 percent) of arterial ischemic stroke (n = 925) and 170 of 262 cases (65 percent) of cerebral sinovenous thrombosis cases [8]. The explanation for the apparent male predominance is unknown.

Young adults – In adults <45 years old, the incidence of ischemic stroke worldwide ranges from 8 to 100/100,000 people per year [9,10]. In the United States, the incidence of ischemic stroke in young Black adults is higher than in young White adults [11], and young Black adults are more likely to have multiple atherosclerotic risk factors (hypertension, obesity, diabetes, and smoking) compared with young White adults [12].

The reported incidence of ischemic stroke in young adults has increased since the 1980s; potential reasons include improved stroke diagnostic methods with neuroimaging, increased prevalence of risk factors, and increased use of illicit drugs [13-16]. (See 'Substance use' below.)

ETIOLOGIES AND RISK FACTORS

Differences among age groups — The etiologies and risk factors for arterial ischemic stroke in children and young adults differ from those typical in older adults. In children and young adults, congenital and acquired heart problems, hematologic conditions, vasculopathies, metabolic disorders, and drug ingestion are more common compared with older adults (table 1). These are discussed individually below. While some etiologies are mainly descriptive (eg, vasculopathy) and some pathogenic (eg, infection), there is often overlap among them (eg, infection may cause arteriopathy).

In older adults, hypertension, smoking, diabetes, and hypercholesterolemia are more common. These risk factors are also present in some young adults [17-20] and rarely in children [20,21].

Etiologies and risk factors in children — The most common etiologies and risk factors for ischemic stroke in children include cardiac abnormalities, vascular lesions (eg, focal cerebral arteriopathy), hematologic abnormalities, infection, head and neck trauma, and genetic conditions [21-25]. The incidence of these factors varies greatly depending on the population being studied.

Data on pediatric stroke come from several population-based or referral-based cohorts, as well as smaller case series. None were conducted with standardized evaluations in all patients, so the true incidence of risk factors cannot be inferred. In a multicenter report that evaluated over 600 children (age 29 days to 18 years) with arterial ischemic stroke identified from the referral-based cohort of the International Pediatric Stroke Study (IPSS), the most frequent conditions associated with arterial ischemic stroke were arteriopathy, cardiac disorders, and infection, seen in 53, 31, and 24 percent, respectively [23,24].

Etiologies and risk factors in young adults — In young adults with stroke, data on causes and risk factors come from a few single center or population-based cohorts. Conditions associated with ischemic stroke include vasculopathy (such as arterial dissection), cardiac defects, recent pregnancy, other hypercoagulable states, smoking, illicit drug use, premature atherosclerosis, hypertension, low physical activity, high body mass index in adolescents, metabolic disorders, and possibly migraine [1,19,26-31]. Rare cases of focal cerebral arteriopathy have also been reported [32].

One of the largest cohorts consisted of 1008 consecutive patients (15 to 49 years of age) with first-ever ischemic stroke from Finland [1]. Overall, the most frequent risk factors were dyslipidemia, smoking, and hypertension, found in 60, 44, and 39 percent, respectively. The most common etiologies were cardioembolism and cervicocephalic arterial dissection in 20 and 15 percent respectively; the proportions of small vessel disease and large artery atherosclerosis (14 and 8 percent) increased beginning at age 30 to 35, while the frequency of undetermined etiology (33 percent) decreased with age (figure 2). As noted previously, stroke occurrence increased exponentially with age (figure 1).

Estrogen-containing contraceptive use is associated with stroke, but some studies with formulations containing low-dose estradiol have not confirmed this association. (See "Combined estrogen-progestin contraception: Side effects and health concerns", section on 'Cardiovascular effects'.)

Arteriopathy — Abnormalities of the cerebral vasculature, whether inherited or acquired, predispose to arterial ischemic stroke in the young. Arteriopathy is defined as the imaging appearance of an in-situ arterial abnormality (ie, stenosis, irregularity, occlusion, banding, pseudoaneurysm, dissection flap) that is not attributable to an exogenous thrombus (eg, cardioembolism) and is not considered a normal developmental variant [33].

Arteriopathies can be divided into noninflammatory and inflammatory etiologies [34,35]. A report from the IPSS of 2127 children (age 1 month to 18 years) with arterial ischemic stroke identified arteriopathy in 725 (34 percent) [36]. In the 725 cases with arteriopathy, the following subtypes were reported:

Craniocervical dissection, 27 percent

Moyamoya disease, 24 percent

Focal cerebral arteriopathy, inflammatory subtype (FCA-i), 15 percent

Diffuse cerebral vasculitis, 15 percent

Other arteriopathy, 19 percent

In the IPSS, variables associated with arteriopathy compared with no arteriopathy included age between six to nine years, headache, multiple infarctions, sickle cell anemia, and head or neck trauma [36].

Childhood arteriopathy subtypes can be challenging to distinguish, particularly in the acute setting. However, typical clinical characteristics and imaging features can aid in classification [37]. Intracranial arterial wall imaging is useful in identifying inflammatory versus non-inflammatory etiologies. (See "Ischemic stroke in children: Clinical presentation, evaluation, and diagnosis", section on 'Arterial wall imaging'.)

Focal cerebral arteriopathy — Focal cerebral arteriopathy of childhood (FCA) is the term originally used by the IPSS to describe an unexplained, nonatherosclerotic, unilateral focal arterial stenosis in a child with arterial ischemic stroke [23]. The term FCA now defines a specific angiographic appearance of unifocal and unilateral stenosis or irregularity of one of the large intracranial arteries of the anterior circulation (distal internal carotid artery and/or its proximal branches) [37]. Some investigators recognize two subtypes:

FCA-dissection type (FCA-d) — FCA-d includes intracranial but not extracranial dissection of the anterior circulation. In children, intracranial dissection can be difficult to distinguish from FCA-i based upon radiographic imaging features alone, as demonstrated by post-mortem cases [37,38].

FCA-inflammatory type (FCA-i) — FCA-i includes cases others have labeled transient cerebral arteriopathy (TCA) and is thought to represent a focal vasculitis in most cases. In the IPSS, single infarctions and hemiparesis were clinical presentations associated with FCA-i [36].

Possible causes of FCA-i are inflammation and vasculitis due to infection (eg, antecedent varicella infection) or autoimmune disease [35,39-43] (see 'Infection' below). Other possible causes of FCA include thromboembolic arterial occlusion or stenosis followed by variable recanalization, arterial spasm, and prothrombotic factors [39,40].

TCA was originally defined as a monophasic transient arteriopathy characterized, on serial vascular imaging, by a nonprogressive unilateral focal or segmental stenosis or occlusion of the distal internal carotid and/or initial segments of the large intracranial arteries [34].

A segmental banding pattern (image 1) is considered a pathognomonic feature of FCA-i (TCA), but is only present in approximately one-quarter of cases [37]. A report of cases labeled TCA found that the stenosis may worsen in the first three months after stroke, sometimes associated with new neurologic symptoms, but stabilizes and can even improve by six months after initial presentation [44]. While the term "transient" in TCA implies complete resolution, some patients are left with some degree of residual arterial stenosis [34,45].

Ischemic stroke associated with FCA often occurs in the distribution of the lenticulostriate branches that arise from the proximal segments of the middle cerebral artery and anterior cerebral artery, supplying the basal ganglia and internal capsule [44,45]. In a subset of cases, this finding is associated with antecedent varicella infection [39,45,46]; other viral infections may underlie the pathophysiology in idiopathic cases.

Moyamoya — Moyamoya syndrome is characterized by progressive stenosis of the internal carotid arteries and formation of collateral vessels that give a "puff of smoke" appearance on angiography. Moyamoya disease occurs mainly in Japanese and other Asian populations and may have a genetic basis. In the IPSS, seizures and recurrent strokes were associated with moyamoya [36].

Secondary moyamoya syndrome is seen in association with neurofibromatosis, trisomy 21, Williams syndrome, sickle cell disease, congenital dwarfism, and as a sequela of cranial irradiation. In children, moyamoya typically presents with recurrent transient ischemic attacks (TIAs) or ischemic strokes, while intracranial hemorrhage is more common in young adults. (See "Moyamoya disease and moyamoya syndrome: Etiology, clinical features, and diagnosis".)

Extracranial dissection — Extracranial arterial dissection of the carotid and vertebral arteries is a common vascular abnormality in some young adult series [17,30,47-49], and is a cause of stroke in children as well [3,6,21,50]. While definite or probable trauma is identified in some patients, spontaneous dissection also occurs. Connective tissue disorders such as vascular Ehlers-Danlos syndrome and Marfan syndrome can predispose to dissection. (See "Cerebral and cervical artery dissection: Clinical features and diagnosis".)

Intracranial dissection, termed FCA-d in childhood stroke, is discussed above. (See 'FCA-dissection type (FCA-d)' above.)

In the IPSS, head and neck trauma were associated with both intracranial and extracranial dissection. Headache was associated with intracranial dissection, while male sex and posterior circulation involvement were associated with extracranial dissection [36].

Diffuse vasculitis — Vasculitis (inflammatory changes in the cerebral vessels) can be primary or secondary. In the IPSS, bilateral infarctions and acute systemic findings were associated with vasculitis [36].

Primary vasculitides associated with stroke include:

Takayasu arteritis (see "Clinical features and diagnosis of Takayasu arteritis")

Giant cell arteritis (see "Clinical manifestations of giant cell arteritis")

Polyarteritis nodosa (see "Clinical manifestations and diagnosis of polyarteritis nodosa in adults")

Kawasaki disease (see "Kawasaki disease: Clinical features and diagnosis")

Primary angiitis of the central nervous system (see "Primary angiitis of the central nervous system in adults")

Adenosine deaminase 2 (ADA2) deficiency, caused by CECR1 pathogenic variants, is a cause of early childhood stroke that may mimic polyarteritis nodosa [51-53]. Variable clinical features of this condition include intermittent fevers, proteinuria, hypertension, peripheral neuropathy, humoral immunodeficiency, and skin disease (eg, livedo reticularis, hand nodules).

Secondary vasculitides due to collagen vascular diseases such as lupus or infections are also associated with stroke:

Systemic lupus erythematosus (see "Childhood-onset systemic lupus erythematosus (SLE): Clinical manifestations and diagnosis" and "Clinical manifestations and diagnosis of systemic lupus erythematosus in adults")

Bacterial meningitis (see "Bacterial meningitis in children: Neurologic complications", section on 'Cerebrovascular complications' and "Clinical features and diagnosis of acute bacterial meningitis in adults")

HIV [54,55] (see "Pediatric HIV infection: Classification, clinical manifestations, and outcome", section on 'Other')

Varicella [46] (see "Clinical features of varicella-zoster virus infection: Chickenpox")

Syphilis (see "Neurosyphilis")

Central nervous system tuberculosis (see "Central nervous system tuberculosis: An overview")

Monogenic arteriopathies

Arterial tortuosity syndrome, caused by pathogenic variants in SLC2A10 [56].

CADASIL (cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy), caused by pathogenic variants in the NOTCH3 gene, which leads to progressive degeneration of smooth muscle cells in the vessel wall. The underlying vascular lesion in CADASIL is a nonatherosclerotic angiopathy involving small arteries and capillaries, primarily in the brain. Patients with CADASIL may present with migraine, TIA, or ischemic stroke in late childhood or early adulthood. (See "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)".)

CARASAL (cathepsin A–related arteriopathy with strokes and leukoencephalopathy), caused by pathogenic variants in the CTSA gene [57,58].

CARASIL (cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy), due to pathogenic variants of the HTRA1 gene [59].

Other vascular abnormalities — Other abnormalities of vessel structure have been associated with ischemic stroke, including the following:

Fibromuscular dysplasia, a nonatherosclerotic, noninflammatory arteriopathy that predominantly affects females [60].

PHACE (syndrome of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities) [61]; children with PHACE syndrome may develop progressive narrowing of the cerebral arteries, which increases the risk for arterial ischemic stroke. (See "PHACE syndrome".)

Hereditary hemorrhagic telangiectasia (HHT), an autosomal dominant vascular disorder with a wide spectrum of clinical manifestations. Patients with HHT may develop pulmonary arteriovenous malformations (AVMs) and various types of cerebrovascular malformations. Ischemic stroke in HHT occurs primarily from paradoxical embolism through a pulmonary AVM [62]. (See "Clinical manifestations and diagnosis of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)".)

Radiation-induced vasculopathies; presumed small or large vessel vasculopathies in childhood cancer survivors exposed to cranial or cervical radiation [63-65].

Rotational vertebral artery syndrome (also called bow hunter syndrome), characterized by symptoms of brainstem or cerebellar ischemia due to compression of the V3 segment of the vertebral artery by bony elements of the spine (typically at C1-C2) that occurs with physiologic head rotation and is more common in boys [22,66-70]. Repeated trauma to the artery leads to the development of pseudoaneurysm and dissection, and in some cases to recurrent posterior circulation arterial ischemic stroke.

RCVS (reversible cerebral vasoconstriction syndrome), which represents a group of conditions characterized by reversible narrowing and dilatation of the cerebral arteries. (See "Reversible cerebral vasoconstriction syndrome".)

RVCL-S (retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations), also known as HERNS (hereditary endotheliopathy, retinopathy, nephropathy, and stroke), due to heterozygous pathogenic variants in TREX1 gene. (See "Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S)".)

Smooth muscle dysfunction syndrome, caused by pathogenic variants in ACTA2 and other genetic abnormalities, and characterized by neurovascular abnormalities (an abnormally straight course of the internal carotid and intracranial arteries, dilation of the proximal internal carotid arteries, and occlusive disease of the terminal internal carotid arteries), aortic disease, pulmonary hypertension, congenital mydriasis and pupillary abnormalities, and presentation in infancy with a patent ductus arteriosus [71-73].

Vasospasm resulting from subarachnoid hemorrhage. (See "Aneurysmal subarachnoid hemorrhage: Treatment and prognosis", section on 'Vasospasm and delayed cerebral ischemia'.)

Cardiac — Congenital and acquired heart disease is a risk factor for cardioembolic stroke, especially in the perioperative period or following catheterization or extracorporeal membrane oxygenation (ECMO) [24,74-81]. Potential mechanisms of ischemic stroke associated with congenital heart disease include the following [75,79]:

Paradoxical embolism

Hyperviscosity (eg, from polycythemia and compensatory erythrocytosis)

Increased risk of infective endocarditis and septic embolism

Propensity to thrombosis (figure 3)

Dilation of cardiac chambers with intracardiac thrombus formation

Arrhythmias

Congenital heart disease remains a stroke risk factor for years after palliative and corrective surgeries. Compared with the general population, the risk of ischemic stroke in young adults (ages 18 to 55 years) with congenital heart disease is 9 to 12 times higher [76], and the risk of stroke in children with congenital heart disease is approximately 19 times higher [82].

Acquired heart disease (eg, myocarditis, endocarditis, cardiomyopathy, and prosthetic valve placement) is also a risk factor for arterial ischemic stroke [81,83,84]. (See "Clinical manifestations and diagnosis of myocarditis in children" and "Infective endocarditis in children".)

The role of common cardiac abnormalities such as PFO and mitral valve prolapse is reviewed separately. (See "Atrial septal abnormalities (PFO, ASD, and ASA) and risk of cerebral emboli in adults" and "Mitral valve prolapse: Overview of complications and their management".)

Infection — There is evidence certain infectious agents may act as direct causes of stroke, while systemic infections may act as nonspecific stroke triggers [85].

Direct causes of stroke – Examples of infections that may cause stroke directly (table 2) include a number of bacterial infections (eg, neurosyphilis, tuberculous meningitis), parasitic infections (eg, Chagas disease, neurocysticercosis, cerebral malaria), fungal infections (cryptococcal meningitis and vasculitis), and viral infections (HIV vasculopathy, herpes simplex virus vasculitis, and varicella-zoster virus vasculitis) [85,86].

Stroke in children and young adults may occur in association with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (coronavirus disease 2019 [COVID-19]). Potential risk factors and mechanisms include established stroke risk factors and those related to COVID-19 (eg, hypercoagulability and proinflammatory state, endothelial dysfunction, and/or cardiogenic embolism). In a survey of international centers that treat pediatric stroke, 23 of 7231 (0.3 percent) children hospitalized with SARS-CoV-2 infection had an arterial ischemic stroke; in 22 of the arterial ischemic stroke cases with sufficient data, SARS-CoV-2 was considered the main stroke risk factor in 6, a possible contributory factor in 13, and an incidental factor in 3 [87]. The relationship between COVID-19 and stroke is reviewed in detail elsewhere. (See "COVID-19: Neurologic complications and management of neurologic conditions", section on 'Cerebrovascular disease'.)

Stroke triggers – Clinical and subclinical childhood infections have been implicated as a trigger for stroke across etiologies, including arteriopathy, cardioembolic, and idiopathic ischemic stroke in children. In an international, multicenter study, infection in the week prior to stroke onset (for 355 cases of children with arterial ischemic stroke) or the week prior to interview date (for 354 stroke-free controls) was significantly more common among cases compared with controls (18 versus 3 percent) [88]. In addition, cases were more likely to have missed some or all of the routinely recommended childhood vaccines (8 versus 1 percent). In multivariable logistic regression analysis, independent risk factors for childhood arterial ischemic stroke included recent infection within one week of stroke (odds ratio [OR] 6.3, 95% CI 3.3-12) and under-vaccination (OR 8.2, 95% CI 2.5-26).

In a subsequent report from the same group, serologic evidence of an acute herpesvirus infection was associated with a twofold increase in the odds of arterial ischemic stroke compared with controls (OR 2.2, 95% CI 1.2-4.0) [89]. Among the subset of 187 stroke cases with both acute and convalescent blood samples, serologic evidence of acute herpesvirus infection was present in 45 percent. Most of these infections were asymptomatic.

Infections with parvovirus B19 [90] and varicella-zoster virus [91] have also been implicated as triggers in childhood stroke.

Hematologic

Sickle cell disease — Sickle cell disease is a common cause of stroke in children, with a rate approximately 200 times higher than that seen in children without sickle cell disease [22]. The rate is highest in hemoglobin SS and hemoglobin S-beta thalassemia. This issue is discussed in detail elsewhere. (See "Prevention of stroke (initial or recurrent) in sickle cell disease", section on 'Incidence'.)

Prothrombotic disorders

Children – Numerous other inherited or acquired prothrombotic disorders have been associated with pediatric stroke in case series, case-control studies, and prospective cohorts [21,92-96]. These include:

Anemia (particularly iron deficiency)

Antiphospholipid syndrome

Abnormal activated protein C resistance (usually related to the Factor V Leiden)

Protein C deficiency

Protein S deficiency

Antithrombin deficiency

Prothrombin G20210A

Elevated lipoprotein(a)

Elevated homocysteine

The strongest evidence supporting an association of prothrombotic conditions with pediatric stroke comes from a meta-analysis of 22 observational studies that included 1526 children with arterial ischemic stroke, 238 with cerebral venous sinus thrombosis, and 2799 control subjects [97]. Odds ratios (ORs) for arterial ischemic stroke were as follows:

Two or more genetic thrombophilias, OR 18.6 (95% CI 6.5-54.1)

Protein C deficiency, OR 11.0 (95% CI 5.1-23.6)

Antiphospholipid antibodies/lupus anticoagulant, OR 7.0 (95% CI 3.7-13.1)

Elevated lipoprotein(a), OR 6.5 (95% CI 4.5-9.6)

Factor V Leiden, OR 3.7 (95% CI 2.8-4.9)

Antithrombin deficiency, OR 3.3 (95% CI 0.7-15.5)

Prothrombin G20210A, OR 2.6 (95% CI 1.7-4.1)

MTHFR TT genotype, OR 1.6 (95% CI 1.2-2.1)

Protein S deficiency, OR 1.5 (95% CI 0.3-6.9)

The association with arterial ischemic stroke was statistically significant for all of the above traits except antithrombin deficiency and protein S deficiency [97]. The strength of these findings is limited by the observational methodology of the included studies, the uncertain quality of the control group, and the potential for confounding from transient acquired abnormalities of some thrombophilic factors [97,98].

Young adults – In young adults, several of these prothrombotic factors are associated with venous thromboembolism but not clearly with arterial ischemic stroke [99]. Because of the small size of many of the studies reporting associated prothrombotic abnormalities in patients with stroke and the high frequency of some of these abnormalities in the general population, the precise contribution of these prothrombotic states to stroke pathophysiology remains unclear. Nevertheless, there are data suggesting that antiphospholipid antibodies [100], and possibly factor V Leiden [101], contribute to stroke risk in young adults.

Prothrombotic medications such as L-asparaginase and oral contraceptives are also associated with stroke. (See "Combined estrogen-progestin contraception: Side effects and health concerns", section on 'Cardiovascular effects'.)

Metabolic disorders — Several metabolic conditions are associated with arterial ischemic stroke, generally through effects on the vessel wall.

Fabry disease, an X-linked lysosomal disease due to deficiency of alpha-galactosidase A, may result in vessel narrowing and infarction in affected young adult males and carrier females. (See "Fabry disease: Neurologic manifestations".)

Homocystinuria is a rare condition associated with stroke in which elevated plasma homocysteine results from a deficiency of cystathionine beta-synthase. Thromboembolism has been implicated as the stroke mechanism in a small case series and case reports [102-104].

Menkes disease, a rare X-linked condition resulting in impaired copper transport, is associated with cerebral vessel tortuosity and stroke [105].

Deficiency of adenosine deaminase 2 (ADA2) is a rare disorder characterized by recurrent fever, vasculopathy, childhood stroke, and mild immunodeficiency [52]. Common manifestations include ischemic or hemorrhagic stroke in small vessel distributions, livedoid rash, and hepatosplenomegaly. The condition is caused by loss-of-function pathogenic variants in the CECR1 gene that encodes adenosine deaminase 2. Inheritance is autosomal recessive.

Mitochondrial disorders — Some mitochondrial disorders are associated with metabolic stroke. This category includes mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) and disorders caused by pathogenic variants in the POLG gene (ie, POLG-related disorders). (See "Mitochondrial myopathies: Clinical features and diagnosis", section on 'MELAS' and "Ischemic stroke in children: Clinical presentation, evaluation, and diagnosis", section on 'Rare causes of stroke'.)

Substance use — Use of sympathomimetic drugs, such as cocaine and methamphetamine, can cause stroke due to hypertension, vasospasm, or vasculitis [106-108]. Other substances linked to stroke by epidemiologic data include heroin, other opiates, marijuana, synthetic cannabinoids ("spice"), and gamma hydroxybutyrate [109-112]. (See "Substance use disorder in adolescents: Epidemiology, clinical features, assessment, and diagnosis" and "Substance use disorder in adolescents: Treatment overview".)

Substance use among young adults may be increasing over time since the 1990s. One report from the Greater Cincinnati Northern Kentucky Stroke Study found that substance use, documented by toxicology screening in young adults with stroke, increased from 4.4 percent of cases in 1993/1994 to 28.8 percent of cases in 2015 [113].

SOCIETY GUIDELINE LINKS — Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See "Society guideline links: Stroke in children".)

SUMMARY

The etiologies and risk factors for arterial ischemic stroke in children and young adults differ from those typical in older adults, although hypertension, smoking, diabetes, and hypercholesterolemia are found in some young adults and rarely in children. Conditions commonly associated with arterial ischemic stroke in children and young adults (table 1) include congenital and acquired cardiac lesions, arteriopathies, hematologic abnormalities, infection, head and neck trauma, and genetic conditions. (See 'Etiologies and risk factors' above.)

Arterial dissection is the most common vascular abnormality in some young adult series. Additional risk factors in young adults include recent pregnancy, drug use, premature atherosclerosis, and possibly migraine. (See 'Etiologies and risk factors in young adults' above.)

Arteriopathies are the most common cause of stroke in children. Abnormalities of the cerebral vasculature that predispose to arterial ischemic stroke include arterial dissection, focal (or transient) cerebral arteriopathy of childhood, fibromuscular dysplasia, moyamoya syndrome, and vasculitis. (See 'Arteriopathy' above.)

Congenital and acquired heart disease is an established risk factor for stroke in children and young adults. (See 'Cardiac' above.)

Acute clinical and subclinical infections may act as a trigger for stroke in children who have other risk factors such as cardiac disease, sickle cell disease, or arteriopathies. (See 'Infection' above.)

Sickle cell disease and several inherited or acquired prothrombotic disorders have been associated with stroke in children and young adults. (See 'Hematologic' above.)

Metabolic conditions associated with arterial ischemic stroke, generally through effects on the vessel wall, include Fabry disease, homocystinuria, and Menkes disease. (See 'Metabolic disorders' above.)

Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) and other rare mitochondrial disorders are associated with metabolic stroke. (See 'Mitochondrial disorders' above.)

  1. Putaala J, Metso AJ, Metso TM, et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke 2009; 40:1195.
  2. Giroud M, Lemesle M, Gouyon JB, et al. Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol 1995; 48:1343.
  3. Earley CJ, Kittner SJ, Feeser BR, et al. Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology 1998; 51:169.
  4. Tuckuviene R, Christensen AL, Helgestad J, et al. Paediatric arterial ischaemic stroke and cerebral sinovenous thrombosis in Denmark 1994-2006: a nationwide population-based study. Acta Paediatr 2011; 100:543.
  5. deVeber GA, Kirton A, Booth FA, et al. Epidemiology and Outcomes of Arterial Ischemic Stroke in Children: The Canadian Pediatric Ischemic Stroke Registry. Pediatr Neurol 2017; 69:58.
  6. Sträter R, Becker S, von Eckardstein A, et al. Prospective assessment of risk factors for recurrent stroke during childhood--a 5-year follow-up study. Lancet 2002; 360:1540.
  7. Fullerton HJ, Wu YW, Zhao S, Johnston SC. Risk of stroke in children: ethnic and gender disparities. Neurology 2003; 61:189.
  8. Golomb MR, Fullerton HJ, Nowak-Gottl U, et al. Male predominance in childhood ischemic stroke: findings from the international pediatric stroke study. Stroke 2009; 40:52.
  9. Marini C, Russo T, Felzani G. Incidence of stroke in young adults: a review. Stroke Res Treat 2010; 2011:535672.
  10. Sarfo FS, Ovbiagele B, Gebregziabher M, et al. Stroke Among Young West Africans: Evidence From the SIREN (Stroke Investigative Research and Educational Network) Large Multisite Case-Control Study. Stroke 2018; 49:1116.
  11. Kittner SJ, McCarter RJ, Sherwin RW, et al. Black-white differences in stroke risk among young adults. Stroke 1993; 24:I13.
  12. Mehndiratta P, Ryan KA, Cronin C, et al. Differences in Multiple Risk Factors Between Black and White Individuals With Young-Onset Ischemic Stroke. Neurology 2022; 99:e560.
  13. Ekker MS, Boot EM, Singhal AB, et al. Epidemiology, aetiology, and management of ischaemic stroke in young adults. Lancet Neurol 2018; 17:790.
  14. Béjot Y, Delpont B, Giroud M. Rising Stroke Incidence in Young Adults: More Epidemiological Evidence, More Questions to Be Answered. J Am Heart Assoc 2016; 5.
  15. Kissela BM, Khoury JC, Alwell K, et al. Age at stroke: temporal trends in stroke incidence in a large, biracial population. Neurology 2012; 79:1781.
  16. Li L, Scott CA, Rothwell PM. Association of Younger vs Older Ages With Changes in Incidence of Stroke and Other Vascular Events, 2002-2018. JAMA 2022; 328:563.
  17. Leys D, Bandu L, Hénon H, et al. Clinical outcome in 287 consecutive young adults (15 to 45 years) with ischemic stroke. Neurology 2002; 59:26.
  18. Naess H, Waje-Andreassen U, Thomassen L, et al. Do all young ischemic stroke patients need long-term secondary preventive medication? Neurology 2005; 65:609.
  19. Ji R, Schwamm LH, Pervez MA, Singhal AB. Ischemic stroke and transient ischemic attack in young adults: risk factors, diagnostic yield, neuroimaging, and thrombolysis. JAMA Neurol 2013; 70:51.
  20. Poisson SN, Hills NK, Sidney S, Fullerton HJ. Prevalence of Atherosclerotic Risk Factors Among Children and Young Adults With Arterial Ischemic Stroke. JAMA Neurol 2022; 79:901.
  21. Ganesan V, Prengler M, McShane MA, et al. Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 2003; 53:167.
  22. Ferriero DM, Fullerton HJ, Bernard TJ, et al. Management of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association. Stroke 2019; 50:e51.
  23. Amlie-Lefond C, Bernard TJ, Sébire G, et al. Predictors of cerebral arteriopathy in children with arterial ischemic stroke: results of the International Pediatric Stroke Study. Circulation 2009; 119:1417.
  24. Mackay MT, Wiznitzer M, Benedict SL, et al. Arterial ischemic stroke risk factors: the International Pediatric Stroke Study. Ann Neurol 2011; 69:130.
  25. Hills NK, Johnston SC, Sidney S, et al. Recent trauma and acute infection as risk factors for childhood arterial ischemic stroke. Ann Neurol 2012; 72:850.
  26. Kittner SJ, Stern BJ, Feeser BR, et al. Pregnancy and the risk of stroke. N Engl J Med 1996; 335:768.
  27. de los Ríos F, Kleindorfer DO, Khoury J, et al. Trends in substance abuse preceding stroke among young adults: a population-based study. Stroke 2012; 43:3179.
  28. von Sarnowski B, Schminke U, Tatlisumak T, et al. Prevalence of stenoses and occlusions of brain-supplying arteries in young stroke patients. Neurology 2013; 80:1287.
  29. Aigner A, Grittner U, Rolfs A, et al. Contribution of Established Stroke Risk Factors to the Burden of Stroke in Young Adults. Stroke 2017; 48:1744.
  30. Rasura M, Spalloni A, Ferrari M, et al. A case series of young stroke in Rome. Eur J Neurol 2006; 13:146.
  31. Bardugo A, Fishman B, Libruder C, et al. Body Mass Index in 1.9 Million Adolescents and Stroke in Young Adulthood. Stroke 2021; 52:2043.
  32. McKenna MC, Fanning N, Cronin S. Focal Cerebral Arteriopathy in Young Adult Patients With Stroke. Stroke 2020; 51:1596.
  33. Wintermark M, Hills NK, deVeber GA, et al. Arteriopathy diagnosis in childhood arterial ischemic stroke: results of the vascular effects of infection in pediatric stroke study. Stroke 2014; 45:3597.
  34. Sébire G, Fullerton H, Riou E, deVeber G. Toward the definition of cerebral arteriopathies of childhood. Curr Opin Pediatr 2004; 16:617.
  35. Mineyko A, Kirton A. Mechanisms of pediatric cerebral arteriopathy: an inflammatory debate. Pediatr Neurol 2013; 48:14.
  36. Rafay MF, Shapiro KA, Surmava AM, et al. Spectrum of cerebral arteriopathies in children with arterial ischemic stroke. Neurology 2020; 94:e2479.
  37. Wintermark M, Hills NK, DeVeber GA, et al. Clinical and Imaging Characteristics of Arteriopathy Subtypes in Children with Arterial Ischemic Stroke: Results of the VIPS Study. AJNR Am J Neuroradiol 2017; 38:2172.
  38. Dlamini N, Freeman JL, Mackay MT, et al. Intracranial dissection mimicking transient cerebral arteriopathy in childhood arterial ischemic stroke. J Child Neurol 2011; 26:1203.
  39. Danchaivijitr N, Cox TC, Saunders DE, Ganesan V. Evolution of cerebral arteriopathies in childhood arterial ischemic stroke. Ann Neurol 2006; 59:620.
  40. Sébire G. Transient cerebral arteriopathy in childhood. Lancet 2006; 368:8.
  41. Mineyko A, Narendran A, Fritzler ML, et al. Inflammatory biomarkers of pediatric focal cerebral arteriopathy. Neurology 2012; 79:1406.
  42. Lanthier S, Armstrong D, Domi T, deVeber G. Post-varicella arteriopathy of childhood: natural history of vascular stenosis. Neurology 2005; 64:660.
  43. Miravet E, Danchaivijitr N, Basu H, et al. Clinical and radiological features of childhood cerebral infarction following varicella zoster virus infection. Dev Med Child Neurol 2007; 49:417.
  44. Chabrier S, Rodesch G, Lasjaunias P, et al. Transient cerebral arteriopathy: a disorder recognized by serial angiograms in children with stroke. J Child Neurol 1998; 13:27.
  45. Braun KP, Bulder MM, Chabrier S, et al. The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke. Brain 2009; 132:544.
  46. Askalan R, Laughlin S, Mayank S, et al. Chickenpox and stroke in childhood: a study of frequency and causation. Stroke 2001; 32:1257.
  47. Cerrato P, Grasso M, Imperiale D, et al. Stroke in young patients: etiopathogenesis and risk factors in different age classes. Cerebrovasc Dis 2004; 18:154.
  48. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998; 91:288.
  49. Nedeltchev K, der Maur TA, Georgiadis D, et al. Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry 2005; 76:191.
  50. Nash M, Rafay MF. Craniocervical Arterial Dissection in Children: Pathophysiology and Management. Pediatr Neurol 2019; 95:9.
  51. Caorsi R, Penco F, Grossi A, et al. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. Ann Rheum Dis 2017; 76:1648.
  52. Zhou Q, Yang D, Ombrello AK, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 2014; 370:911.
  53. Lee PY. Vasculopathy, Immunodeficiency, and Bone Marrow Failure: The Intriguing Syndrome Caused by Deficiency of Adenosine Deaminase 2. Front Pediatr 2018; 6:282.
  54. Ortiz G, Koch S, Romano JG, et al. Mechanisms of ischemic stroke in HIV-infected patients. Neurology 2007; 68:1257.
  55. Tipping B, de Villiers L, Wainwright H, et al. Stroke in patients with human immunodeficiency virus infection. J Neurol Neurosurg Psychiatry 2007; 78:1320.
  56. Beyens A, Albuisson J, Boel A, et al. Arterial tortuosity syndrome: 40 new families and literature review. Genet Med 2018; 20:1236.
  57. Bugiani M, Kevelam SH, Bakels HS, et al. Cathepsin A-related arteriopathy with strokes and leukoencephalopathy (CARASAL). Neurology 2016; 87:1777.
  58. Finsterer J, Scorza CA, Scorza FA, Wakil SM. Update on hereditary, autosomal dominant cathepsin-A-related arteriopathy with strokes and leukoencephalopathy (CARASAL). Acta Neurol Belg 2019; 119:299.
  59. Onodera O, Nozaki H, Fukutake T. HTRA1 disorder. In: GeneReviews [Internet], Adam MP, Ardinger HH, Pagon RA, et al. (Eds), University of Washington, Seattle 2019. https://www.ncbi.nlm.nih.gov/books/NBK32533/ (Accessed on January 15, 2020).
  60. Kirton A, Crone M, Benseler S, et al. Fibromuscular dysplasia and childhood stroke. Brain 2013; 136:1846.
  61. Siegel DH, Tefft KA, Kelly T, et al. Stroke in children with posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities (PHACE) syndrome: a systematic review of the literature. Stroke 2012; 43:1672.
  62. White AJ, Marmor I, Peacock KM, et al. Brain Abscess and Stroke in Children and Adults With Hereditary Hemorrhagic Telangiectasia: Analysis of a Large National Claims Database. Neurology 2023; 100:e2324.
  63. Campen CJ, Kranick SM, Kasner SE, et al. Cranial irradiation increases risk of stroke in pediatric brain tumor survivors. Stroke 2012; 43:3035.
  64. Mueller S, Sear K, Hills NK, et al. Risk of first and recurrent stroke in childhood cancer survivors treated with cranial and cervical radiation therapy. Int J Radiat Oncol Biol Phys 2013; 86:643.
  65. Bavle A, Srinivasan A, Choudhry F, et al. Systematic review of the incidence and risk factors for cerebral vasculopathy and stroke after cranial proton and photon radiation for childhood brain tumors. Neurooncol Pract 2021; 8:31.
  66. Rollins N, Braga B, Hogge A, et al. Dynamic Arterial Compression in Pediatric Vertebral Arterial Dissection. Stroke 2017; 48:1070.
  67. Duan G, Xu J, Shi J, Cao Y. Advances in the Pathogenesis, Diagnosis and Treatment of Bow Hunter's Syndrome: A Comprehensive Review of the Literature. Interv Neurol 2016; 5:29.
  68. Choi KD, Choi JH, Kim JS, et al. Rotational vertebral artery occlusion: mechanisms and long-term outcome. Stroke 2013; 44:1817.
  69. Fox CK, Fullerton HJ, Hetts SW, et al. Single-center series of boys with recurrent strokes and rotational vertebral arteriopathy. Neurology 2020; 95:e1830.
  70. Golomb MR, Ducis KA, Martinez ML. Bow Hunter's Syndrome in Children: A Review of the Literature and Presentation of a New Case in a 12-Year-Old Girl. J Child Neurol 2020; 35:767.
  71. Regalado ES, Mellor-Crummey L, De Backer J, et al. Clinical history and management recommendations of the smooth muscle dysfunction syndrome due to ACTA2 arginine 179 alterations. Genet Med 2018; 20:1206.
  72. D'Arco F, Alves CA, Raybaud C, et al. Expanding the Distinctive Neuroimaging Phenotype of ACTA2 Mutations. AJNR Am J Neuroradiol 2018; 39:2126.
  73. Lauer A, Speroni SL, Patel JB, et al. Cerebrovascular Disease Progression in Patients With ACTA2 Arg179 Pathogenic Variants. Neurology 2021; 96:e538.
  74. Rodan L, McCrindle BW, Manlhiot C, et al. Stroke recurrence in children with congenital heart disease. Ann Neurol 2012; 72:103.
  75. Sinclair AJ, Fox CK, Ichord RN, et al. Stroke in children with cardiac disease: report from the International Pediatric Stroke Study Group Symposium. Pediatr Neurol 2015; 52:5.
  76. Lanz J, Brophy JM, Therrien J, et al. Stroke in Adults With Congenital Heart Disease: Incidence, Cumulative Risk, and Predictors. Circulation 2015; 132:2385.
  77. Mandalenakis Z, Rosengren A, Lappas G, et al. Ischemic Stroke in Children and Young Adults With Congenital Heart Disease. J Am Heart Assoc 2016; 5.
  78. Asakai H, Cardamone M, Hutchinson D, et al. Arterial ischemic stroke in children with cardiac disease. Neurology 2015; 85:2053.
  79. Attar H, Sachdeva A, Sundararajan S. Cardioembolic Stroke in Adults With a History of Congenital Heart Disease. Stroke 2016; 47:e79.
  80. Cheng HH, Rajagopal S, McDavitt E, et al. Stroke in Acquired and Congenital Heart Disease Patients and Its Relationship to Hospital Mortality and Lasting Neurologic Deficits. Pediatr Crit Care Med 2016; 17:976.
  81. Chung MG, Guilliams KP, Wilson JL, et al. Arterial Ischemic Stroke Secondary to Cardiac Disease in Neonates and Children. Pediatr Neurol 2019; 100:35.
  82. Fox CK, Sidney S, Fullerton HJ. Community-based case-control study of childhood stroke risk associated with congenital heart disease. Stroke 2015; 46:336.
  83. Ricci S. Embolism from the heart in the young patient: a short review. Neurol Sci 2003; 24 Suppl 1:S13.
  84. Cao GF, Bi Q. Pediatric Infective Endocarditis and Stroke: A 13-Year Single-Center Review. Pediatr Neurol 2019; 90:56.
  85. Miller EC, Elkind MS. Infection and Stroke: an Update on Recent Progress. Curr Neurol Neurosci Rep 2016; 16:2.
  86. Hauer L, Pikija S, Schulte EC, et al. Cerebrovascular manifestations of herpes simplex virus infection of the central nervous system: a systematic review. J Neuroinflammation 2019; 16:19.
  87. Beslow LA, Agner SC, Santoro JD, et al. International Prevalence and Mechanisms of SARS-CoV-2 in Childhood Arterial Ischemic Stroke During the COVID-19 Pandemic. Stroke 2022; 53:2497.
  88. Fullerton HJ, Hills NK, Elkind MS, et al. Infection, vaccination, and childhood arterial ischemic stroke: Results of the VIPS study. Neurology 2015; 85:1459.
  89. Elkind MS, Hills NK, Glaser CA, et al. Herpesvirus Infections and Childhood Arterial Ischemic Stroke: Results of the VIPS Study. Circulation 2016; 133:732.
  90. Fullerton HJ, Luna JM, Wintermark M, et al. Parvovirus B19 Infection in Children With Arterial Ischemic Stroke. Stroke 2017; 48:2875.
  91. Helmuth IG, Mølbak K, Uldall PV, Poulsen A. Post-varicella Arterial Ischemic Stroke in Denmark 2010 to 2016. Pediatr Neurol 2018; 80:42.
  92. deVeber G, Monagle P, Chan A, et al. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998; 55:1539.
  93. Nowak-Göttl U, Sträter R, Heinecke A, et al. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999; 94:3678.
  94. Kenet G, Sadetzki S, Murad H, et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000; 31:1283.
  95. Maguire JL, deVeber G, Parkin PC. Association between iron-deficiency anemia and stroke in young children. Pediatrics 2007; 120:1053.
  96. Sarecka-Hujar B, Kopyta I, Skrzypek M, Sordyl J. Association Between the 20210G>A Prothrombin Gene Polymorphism and Arterial Ischemic Stroke in Children and Young Adults-Two Meta-analyses of 3586 Cases and 6440 Control Subjects in Total. Pediatr Neurol 2017; 69:93.
  97. Kenet G, Lütkhoff LK, Albisetti M, et al. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation 2010; 121:1838.
  98. Trenor CC 3rd, Michelson AD. Thrombophilia and pediatric stroke. Circulation 2010; 121:1795.
  99. Waddy SP. Disorders of coagulation in stroke. Semin Neurol 2006; 26:57.
  100. Sciascia S, Sanna G, Khamashta MA, et al. The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review. Ann Rheum Dis 2015; 74:2028.
  101. Hamedani AG, Cole JW, Mitchell BD, Kittner SJ. Meta-analysis of factor V Leiden and ischemic stroke in young adults: the importance of case ascertainment. Stroke 2010; 41:1599.
  102. Kelly PJ, Furie KL, Kistler JP, et al. Stroke in young patients with hyperhomocysteinemia due to cystathionine beta-synthase deficiency. Neurology 2003; 60:275.
  103. Alehan F, Saygi S, Gedik S, Kayahan Ulu EM. Stroke in early childhood due to homocystinuria. Pediatr Neurol 2010; 43:294.
  104. Ruhoy IS, Merritt JL 2nd, Amlie-Lefond C. Cystathionine beta-synthase deficiency heralded by cerebral sinus venous thrombosis and stroke. Pediatr Neurol 2014; 50:108.
  105. Hsich GE, Robertson RL, Irons M, et al. Cerebral infarction in Menkes' disease. Pediatr Neurol 2000; 23:425.
  106. Cheng YC, Ryan KA, Qadwai SA, et al. Cocaine Use and Risk of Ischemic Stroke in Young Adults. Stroke 2016; 47:918.
  107. De Silva DA, Wong MC, Lee MP, et al. Amphetamine-associated ischemic stroke: clinical presentation and proposed pathogenesis. J Stroke Cerebrovasc Dis 2007; 16:185.
  108. Lappin JM, Darke S, Farrell M. Stroke and methamphetamine use in young adults: a review. J Neurol Neurosurg Psychiatry 2017; 88:1079.
  109. Yeung M, Bhalla A, Birns J. Recreational drug misuse and stroke. Curr Drug Abuse Rev 2011; 4:286.
  110. Wolff V, Armspach JP, Lauer V, et al. Cannabis-related stroke: myth or reality? Stroke 2013; 44:558.
  111. Esse K, Fossati-Bellani M, Traylor A, Martin-Schild S. Epidemic of illicit drug use, mechanisms of action/addiction and stroke as a health hazard. Brain Behav 2011; 1:44.
  112. Freeman MJ, Rose DZ, Myers MA, et al. Ischemic stroke after use of the synthetic marijuana "spice". Neurology 2013; 81:2090.
  113. Madsen TE, Cummings OW, De Los Rios La Rosa F, et al. Substance Use and Performance of Toxicology Screens in the Greater Cincinnati Northern Kentucky Stroke Study. Stroke 2022; 53:3082.
Topic 6213 Version 52.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟